Antiphospholipid syndrome, antiphospholipid antibodies, and atherosclerosis (Q34271982)

1 August 2017

1 reference

title

Antiphospholipid syndrome, antiphospholipid antibodies, and atherosclerosis (English)

1 reference

antiphospholipid syndrome

1 August 2017

1 reference

1 reference

1 reference

2

Shoenfeld Y

1 reference

1 August 2017

1

Sherer Y

1 reference

1 August 2017

1 July 2001

1 reference

Current Atherosclerosis Reports

1 August 2017

1 reference

1 August 2017

3

1 reference

1 August 2017

4

1 reference

1 August 2017

328-333

1 reference

https://scigraph.springernature.com/pub.10.1007/s11883-001-0027-6

1 August 2017

0 references

cites work

Immunolocalization of beta2-glycoprotein I (apolipoprotein H) to human atherosclerotic plaques: potential implications for lesion progression

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11883-001-0027-6

Autoantibodies against oxidized low density lipoprotein in patients with angiographically verified coronary artery disease.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11883-001-0027-6

Dyslipoproteinemias in systemic lupus erythematosus: influence of disease, activity, and anticardiolipin antibodies.

21 January 2018

1 reference

12 December 2020

Anti-cardiolipin antibodies and risk of myocardial infarction in a prospective cohort of middle-aged men

1 reference

12 December 2020

Crystal structure of human β2-glycoprotein I: implications for phospholipid binding and the antiphospholipid syndrome

1 reference

12 December 2020

Activation of human platelets by the rabbit anticardiolipin antibodies

1 reference

12 December 2020

Involvement of beta 2-glycoprotein I and anticardiolipin antibodies in oxidatively modified low-density lipoprotein uptake by macrophages

1 reference

12 December 2020

Hyperimmunization of apo-E-deficient mice with homologous malondialdehyde low-density lipoprotein suppresses early atherogenesis.

1 reference

12 December 2020

Plasma homocysteine as a risk factor for atherothrombotic events in systemic lupus erythematosus.

1 reference

12 December 2020

Antiphospholipid antibodies from antiphospholipid syndrome patients activate endothelial cells in vitro and in vivo

1 reference

12 December 2020

Hypergammaglobulinemia, circulating anticoagulant, and biologic false positive Wassermann reaction; a study in two cases

1 reference

12 December 2020

Atherosclerosis in LDL-receptor knockout mice is accelerated by immunization with anticardiolipin antibodies

1 reference

12 December 2020

High antibody levels to prothrombin imply a risk of deep venous thrombosis and pulmonary embolism in middle-aged men--a nested case-control study

1 reference

12 December 2020

Autoantibody titers to oxidized low-density lipoprotein in patients with coronary atherosclerosis

1 reference

12 December 2020

Arterial disease in lupus and secondary antiphospholipid syndrome: association with anti-beta2-glycoprotein I antibodies but not with antibodies against oxidized low-density lipoprotein

1 reference

12 December 2020

Autoantibody against oxidised LDL and progression of carotid atherosclerosis

1 reference

12 December 2020

LDL oxidation in patients with severe carotid atherosclerosis. A study of in vitro and in vivo oxidation markers

1 reference

12 December 2020

Effect of lupus anticoagulant on antithrombogenic properties of endothelial cells--inhibition of thrombomodulin-dependent protein C activation

1 reference

12 December 2020

Antiphospholipid antibodies are directed against epitopes of oxidized phospholipids. Recognition of cardiolipin by monoclonal antibodies to epitopes of oxidized low density lipoprotein

1 reference

12 December 2020

Antibodies to adult human endothelial cells cross-react with oxidized low-density lipoprotein and beta 2-glycoprotein I (beta 2-GPI) in systemic lupus erythematosus

1 reference

12 December 2020

GDKV-induced antiphospholipid antibodies enhance thrombosis and activate endothelial cells in vivo and in vitro.

1 reference

12 December 2020

Induction of primary antiphospholipid syndrome in mice by immunization with a human monoclonal anticardiolipin antibody (H-3)

1 reference

12 December 2020

The oxidation hypothesis of atherosclerosis

1 reference

12 December 2020

Enhancement of atherosclerosis in beta-2-glycoprotein I-immunized apolipoprotein E-deficient mice

1 reference

12 December 2020

Coronary artery disease but not coronary calcification is associated with elevated levels of cardiolipin, beta-2-glycoprotein-I, and oxidized LDL antibodies

1 reference

12 December 2020

Anti-cardiolipin antibodies in ischaemic heart disease.

1 reference

12 December 2020

Prevalence and relation to risk factors of carotid atherosclerosis and left ventricular hypertrophy in systemic lupus erythematosus and antiphospholipid antibody syndrome

1 reference

12 December 2020

Induction of early atherosclerosis in LDL-receptor-deficient mice immunized with beta2-glycoprotein I

1 reference

12 December 2020

Effect of immunization with homologous LDL and oxidized LDL on early atherosclerosis in hypercholesterolemic rabbits

1 reference

12 December 2020

Patients with early-onset peripheral vascular disease have increased levels of autoantibodies against oxidized LDL

1 reference

12 December 2020

Autoantibodies against oxidized low-density lipoprotein and cardiolipin in patients with coronary heart disease

1 reference

12 December 2020

Anti-oxidized low density lipoprotein antibody determination as a predictor of restenosis following percutaneous transluminal coronary angioplasty

1 reference

12 December 2020

Antibodies against cardiolipin and oxidatively modified LDL in 50-year-old men predict myocardial infarction

1 reference

12 December 2020

Association of anti-beta 2 glycoprotein I antibodies with lupus-type circulating anticoagulant and thrombosis in systemic lupus erythematosus

1 reference

12 December 2020

Antibodies to prothrombin imply a risk of myocardial infarction in middle-aged men

1 reference

12 December 2020

High Prevalence of Anti-β2 Glycoprotein I Antibodies in Patients with Ischemic Heart Disease

1 reference

12 December 2020

Anticardiolipin antibody-positive serum enhances endothelial cell platelet-activating factor production

1 reference

12 December 2020

Premature morbidity from cardiovascular and cerebrovascular diseases in women with systemic lupus erythematosus

1 reference

12 December 2020

Induction of anti-phospholipid syndrome in naive mice with mouse lupus monoclonal and human polyclonal anti-cardiolipin antibodies

1 reference

12 December 2020

Monoclonal anticardiolipin autoantibodies established from the (New Zealand white x BXSB)F1 mouse model of antiphospholipid syndrome cross-react with oxidized low-density lipoprotein

1 reference

12 December 2020

Coronary calcium and anti-cardiolipin antibody are elevated in patients with typical chest pain

1 reference

12 December 2020

Autoantibodies against oxidized low-density lipoprotein in antiphospholipid syndrome

1 reference

12 December 2020

Adoptive transfer of beta(2)-glycoprotein I-reactive lymphocytes enhances early atherosclerosis in LDL receptor-deficient mice

1 reference

12 December 2020

Antiphospholipid syndrome: insights from animal models

1 reference

12 December 2020

The anticardiolipin syndrome

1 reference

12 December 2020

10.1007/S11883-001-0027-6

Identifiers

DOI

1 reference

PubMed ID

11389799

Dimensions Publication ID

1 August 2017

0 references

1 reference

PubMed ID

11389799